Roche
Search results
Lonza Singapore is a mammalian cell culture and cell and gene therapy CDMO of biopharmaceutical products, including monoclonal antibodies (mAbs), cellular therapeutics and other recombinant proteins.
Lonza is one of the world’s largest healthcare manufacturing organizations, helping pharmaceutical, biotech and nutrition companies to bring their treatments to market.
6 days ago · Find your job opportunity at Lonza and become part of our global teams. Submit your application now and get one step closer to making a meaningful... Learn more
Oct 11, 2021 · Lonza is investing to expand mammalian development services at its Singapore facility; the move will bring additional capacity for cell culture, purification, and analytical services for mammalian biologics.
Oct 7, 2021 · Lonza's expansion in Singapore will establish additional capacity for cell culture, purification, and analytical services for biologics.
Lonza Biologics Tuas Pte Ltd. https://www.lonza.com/about-us/our-locations/tuas-singapore. Lonza is a preferred global partner to the pharmaceutical, biotech, and nutrition markets, focusing on enabling treatments that prevent illness and support healthier lifestyles.
Lonza | 332,535 followers on LinkedIn. A Meaningful Difference for 125 Years | At Lonza, we enable A Healthier World by supporting our healthcare customers on the path to commercialization.
May 22, 2009 · This new facility will broaden the global presence and consolidate Lonza's leading position in the area of Cell Therapy production. The new facility will be located adjacent to Lonza's...
On 31-Aug, Genentech Singapore – which is wholly-owned by Roche, has announced that it will buy Lonza manufacturing facility in Singapore at a purchase price of US$290 million plus additional milestone payments of US$70 million.
At Lonza, we serve the world’s healthcare needs by enabling treatments that prevent illness and support healthier lifestyles. We combine scientific innovation and manufacturing technology to enable our customers to serve their patients and consumers.
